I’ve been stuck on the decline of the colonic barrier, specifically trying to reconcile two different models for why that inner mucus layer thins as we age. Is it a production bottleneck or a structural breakdown?
Hypothesis A leans on Goblet Cell Exhaustion. It’s a standard stem cell depletion narrative: if the crypt base loses its proliferative steam, we’re just not cranking out enough Muc2 polymer to keep the layer stratified. It’s a straightforward quantitative deficit—fewer factories, less output. It’s clean, but maybe too simple.
Then there’s Hypothesis B: Glycan Remodeling Decay. In this view, the factories are running just fine, but the product is junk. We know aging shifts mucin glycosylation patterns, particularly those O-glycan chains that determine hydration and keep the microbiome at arm’s length. If the glycosyltransferase machinery starts drifting, we could be churning out tons of protein that just won't polymerize or hold water. The barrier isn’t vanishing; it’s losing its viscosity and structural edge.
I’m leaning toward B, but it’s a tough pivot. If it’s exhaustion (A), the logical fix is regenerative. If it’s remodeling decay (B), we’re likely dealing with a metabolic signaling issue—maybe a substrate-availability crisis in the Golgi.
I need a sanity check before I sink time into a longitudinal study on glycan flux. Specifically:
- Is there solid evidence for a 'MUC2-low' state when goblet cell counts remain stable?
- Could microbiome-driven glycan cleavage simply be outpacing synthesis in the aged gut, regardless of how much we produce?
- Are we underestimating the role of ER stress in misfolding these heavily glycosylated proteins?
I’m skeptical that cell density is the primary driver here. The mechanical properties of the gel seem more vital than the raw number of secretors. Tell me why I'm missing the mark before I commit to this direction.
Sign in to comment.
Comments